Concepedia

Author

Kevin M. Regan

Mayo Clinic

Also Known As

Kevin M. Regan, Kevin Regan

87

Publications

1.7K

Citations

16

H-Index

36

Concepts

All Affiliations

Mayo ClinicMayo Clinic in ArizonaWinnMedMayo Clinic in FloridaRoswell Park Comprehensive Cancer Center
KM

About

Kevin M. Regan is an author at Mayo Clinic specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

995

2

Cell Biology

6

6

995

3

Engineering

1

1

16

4

Natural Sciences

1

1

335

5

Endocrinology

1

1

69

Kevin M. Regan

×

17

Publications

1.7K

Citations

16

H-Index

YearCitations

Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation

Haojie Huang, Kevin M. Regan, Fang Wang,

Proceedings of the National Academy of Sciences

2005

512

CDK2-Dependent Phosphorylation of FOXO1 as an Apoptotic Response to DNA Damage

Haojie Huang, Kevin M. Regan, Zhenkun Lou,

Science

2006

335

Superoxide Dismutase B Gene (<i>sodB</i>)-Deficient Mutants of<i>Francisella tularensis</i>Demonstrate Hypersensitivity to Oxidative Stress and Attenuated Virulence

Chandra Shekhar Bakshi, Meenakshi Malik, Kevin M. Regan,

Journal of Bacteriology

2006

113

Androgen Deprivation Increases p300 Expression in Prostate Cancer Cells

Hannelore V. Heemers, Thomas J. Sebo, José D. Debes,

Cancer Research

2007

107

Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells

Barbara Schroeder, Travis Vander Steen, Ingrid Espinoza,

Cell Death and Disease

2021

93

Selective Role of an NH2-Terminal WxxLF Motif for Aberrant Androgen Receptor Activation in Androgen Depletion–Independent Prostate Cancer Cells

Scott M. Dehm, Kevin M. Regan, Lucy J. Schmidt,

Cancer Research

2007

83

Androgen Modulation of Coregulator Expression in Prostate Cancer Cells

Hannelore V. Heemers, Kevin M. Regan, Lucy J. Schmidt,

Molecular Endocrinology

2009

69

Androgen Induction of the Androgen Receptor Coactivator Four and a Half LIM Domain Protein-2: Evidence for a Role for Serum Response Factor in Prostate Cancer

Hannelore V. Heemers, Kevin M. Regan, Scott M. Dehm,

Cancer Research

2007

65

RhoA as a Mediator of Clinically Relevant Androgen Action in Prostate Cancer Cells

Lucy J. Schmidt, Kelly Duncan, Neelu Yadav,

Molecular Endocrinology

2012

61

Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer

Hannelore V. Heemers, Lucy J. Schmidt, Zhifu Sun,

Cancer Research

2011

46

Page 1